STOCK TITAN

Omada Health (OMDA) CAO logs option exercises and 4,167-share planned sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4/A

Rhea-AI Filing Summary

Omada Health, Inc. Chief Accounting Officer Craig Gracey executed routine same-day option exercise-and-sale transactions and corrected prior reporting. On June 26, 2026 and June 29, 2026, Gracey exercised stock options at an exercise price of $6.57 per share and sold the resulting common shares in open-market transactions at prices of $20.00 and $21.00 per share. Following these transactions, Gracey directly beneficially owned 15,441 shares of common stock. The amended Form 4 restates an earlier filing to add the previously omitted option exercises and adjusts the reported beneficial ownership. The transactions were made under a Rule 10b5-1 trading plan adopted on March 13, 2026.

Positive

  • None.

Negative

  • None.
Insider Gracey Craig
Role Chief Accounting Officer
Sold 4,167 shs ($85K)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 2,083 $0.00 --
Exercise Common Stock 2,083 $6.57 $14K
Sale Common Stock 2,083 $21.00 $44K
Exercise Stock Option (Right to Buy) 2,084 $0.00 --
Exercise Common Stock 2,084 $6.57 $14K
Sale Common Stock 2,084 $20.00 $42K
Holdings After Transaction: Stock Option (Right to Buy) — 35,417 shares (Direct, null); Common Stock — 17,524 shares (Direct, null)
Footnotes (1)
  1. This Form 4/A restates in its entirety the original Form 4 filed on 6/30/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. 25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Shares sold at $20.00 2,084 shares Common stock sale on June 26, 2026 at $20.00 per share
Shares sold at $21.00 2,083 shares Common stock sale on June 29, 2026 at $21.00 per share
Total shares sold 4,167 shares Aggregate open-market sales reported in this Form 4/A
Option exercise price $6.57 per share Exercise price for stock options converted into common shares
Shares owned after transactions 15,441 shares Common stock beneficially owned directly after reported trades
Option expiration date October 23, 2034 Expiration date for the reported stock option grants
exercise-and-sale transactions financial
"The exercises reported herein were part of same-day exercise-and-sale transactions"
beneficially owned financial
"the amount of securities beneficially owned following the sales was understated"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Rule 10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
vesting financial
"25% of the shares subject to the option vested on the first anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Vesting Commencement Date financial
"measured from September 9, 2024 (the "Vesting Commencement Date")"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transactions did Omada Health (OMDA) report for Craig Gracey?

Omada Health reported that Chief Accounting Officer Craig Gracey exercised stock options and sold the resulting common shares in open-market trades. The filing describes routine same-day exercise-and-sale transactions and updates his reported beneficial ownership after these trades.

How many Omada Health (OMDA) shares did Craig Gracey sell and at what prices?

Craig Gracey sold 2,084 Omada Health common shares at $20.00 per share and 2,083 shares at $21.00 per share. These open-market sales followed exercises of stock options for the same number of shares at a lower exercise price.

What option exercise price did Craig Gracey pay for OMDA shares?

Craig Gracey exercised Omada Health stock options at an exercise price of $6.57 per share. He then sold the resulting common shares at higher market prices of $20.00 and $21.00 per share in open-market transactions reported in the filing.

How many Omada Health (OMDA) shares does Craig Gracey own after these transactions?

After the reported transactions, Craig Gracey beneficially owned 15,441 Omada Health common shares directly. This updated figure reflects the exercised options, the same-day sales, and the correction made by the amended Form 4 to his previously understated holdings.

Why did Omada Health file an amended Form 4/A for Craig Gracey?

The amended Form 4/A was filed to add option exercise transactions that were omitted from the original Form 4. Because those exercises were missing, Gracey’s beneficially owned share amount was understated and has now been corrected in the updated filing.

Were Craig Gracey’s OMDA trades made under a Rule 10b5-1 plan?

Yes. A footnote explains that the transactions were made under a Rule 10b5-1 trading plan adopted by Craig Gracey on March 13, 2026. Such pre-arranged plans automate trading according to preset instructions, reducing the significance of trade timing.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gracey Craig

(Last)(First)(Middle)
C/O OMADA HEALTH, INC.
611 GATEWAY BLVD, SUITE 120

(Street)
SOUTH SAN FRANCISCO CALIFORNIA 94080

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)
06/30/2026
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/26/2026M(1)2,084A$6.5717,525D
Common Stock06/26/2026S(2)2,084D$2015,441(1)D
Common Stock06/29/2026M(1)2,083A$6.5717,524D
Common Stock06/29/2026S(2)2,083D$2115,441(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$6.5706/26/2026M(1)2,084 (3)10/23/2034Common Stock2,084$037,500D
Stock Option (Right to Buy)$6.5706/29/2026M(1)2,083 (3)10/23/2034Common Stock2,083$035,417D
Explanation of Responses:
1. This Form 4/A restates in its entirety the original Form 4 filed on 6/30/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.
2. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
3. 25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
/s/ Nathan Salha, as Attorney-in-Fact for Craig Gracey07/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)